Samsung Biologics Union Schedules Second Labor Mediation Meeting - report

Samsung Biologics Co., Ltd. (207940) and its union scheduled a second labor mediation meeting. Dailian reported the September 15 session on Tuesday.

The parties held a first post-mediation session at the Incheon Regional Labor Relations Commission on Monday. They also plan two company-level bargaining meetings during September. The union said it may begin collective action if negotiations break down. The dispute concerns wages and a collective agreement.

The second post-mediation session is set for 2 p.m. on September 15. Two internal meetings will precede it. The company's market capitalisation was ₩67.2 trillion at Wednesday's close.

Sources

  1. Dailian
Written from the filing or the Korean-language report it cites, not translated from it. Figures against this company's own statements are computed from DART data on kstock. kstock does not issue buy, sell or hold ratings and this is not investment advice.

One Korean filing a day, in English.

kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.

Free. Unsubscribe anytime. Sent by Substack · Privacy